BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qing L, Gu P, Liu M, Shen J, Liu X, Guang R, Ke K, Huang Z, Lee W, Zhao H. Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer. Onco Targets Ther 2020;13:12521-38. [PMID: 33324071 DOI: 10.2147/OTT.S284167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang D, Li Y, Tang Y, Zheng H, Luo W, Li Y, Li Y, Wang Z, Wu S. Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model. Front Genet 2022;13:918705. [DOI: 10.3389/fgene.2022.918705] [Reference Citation Analysis]
2 Xu H, Tang Y, Liu L, Yan J, Qin L. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression. Horm Metab Res 2022;54:481-8. [PMID: 35835145 DOI: 10.1055/a-1872-0546] [Reference Citation Analysis]
3 Li Q, Shen Z, Shen Y, Deng H, Shen Y, Wang J, Zhan G, Zhou C. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma. J Clin Lab Anal 2022;:e24484. [PMID: 35561269 DOI: 10.1002/jcla.24484] [Reference Citation Analysis]
4 Chen X, Hu L, Mao X, Chen H, She Y, Chi H, Zeng H, Guo L, Han Y, Xu Y. Upregulated LINC00922 Promotes Epithelial-Mesenchymal Transition and Indicates a Dismal Prognosis in Gastric Cancer. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/1608936] [Reference Citation Analysis]
5 Li L, Bi Y, Diao S, Li X, Yuan T, Xu T, Huang C, Li J. Exosomal LncRNAs and Hepatocellular Carcinoma: From Basic Research to Clinical Practice. Biochem Pharmacol 2022;:115032. [PMID: 35395241 DOI: 10.1016/j.bcp.2022.115032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li H, Li M, Guo H, Lin G, Huang Q, Qiu M. Integrative Analyses of Circulating mRNA and lncRNA Expression Profile in Plasma of Lung Cancer Patients. Front Oncol 2022;12:843054. [DOI: 10.3389/fonc.2022.843054] [Reference Citation Analysis]
7 Song Z, Wang J. LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion. Bioengineered 2022;13:1507-17. [PMID: 34986743 DOI: 10.1080/21655979.2021.2021063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Nersisyan S, Novosad V, Engibaryan N, Ushkaryov Y, Nikulin S, Tonevitsky A. ECM-Receptor Regulatory Network and Its Prognostic Role in Colorectal Cancer. Front Genet 2021;12:782699. [PMID: 34938324 DOI: 10.3389/fgene.2021.782699] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Lutz CT, Livas L, Presnell SR, Sexton M, Wang P. Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity. J Clin Med 2021;10:5163. [PMID: 34768683 DOI: 10.3390/jcm10215163] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Tan G, Wu A, Li Z, Chen G, Wu Y, Huang S, Chen X, Li G. Bioinformatics analysis based on immune-autophagy-related lncRNAs combined with immune infiltration in bladder cancer. Transl Androl Urol 2021;10:3440-55. [PMID: 34532269 DOI: 10.21037/tau-21-560] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Cui Y, Zhou Z, Chai Y, Che X, Zhang Y. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer. J Oncol 2021;2021:8533464. [PMID: 34484338 DOI: 10.1155/2021/8533464] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
12 Sun J, Li X, Yu E, Liu J, Sun L, He Q, Lu Q. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer. Diagn Pathol 2021;16:45. [PMID: 34006305 DOI: 10.1186/s13000-021-01105-3] [Cited by in F6Publishing: 8] [Reference Citation Analysis]